Orion OYJ (OTCMKTS:ORINY) Hits New 1-Year High – What’s Next?

Shares of Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) reached a new 52-week high during trading on Thursday . The stock traded as high as $46.00 and last traded at $46.00, with a volume of 108 shares traded. The stock had previously closed at $45.8150.

Orion OYJ Price Performance

The company has a quick ratio of 1.48, a current ratio of 2.64 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $12.98 billion, a PE ratio of 18.93 and a beta of 0.07. The stock’s 50-day moving average is $42.57 and its 200 day moving average is $40.05.

Orion OYJ (OTCMKTS:ORINY) last posted its quarterly earnings results on Friday, July 17th. The company reported $0.58 EPS for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%. The business had revenue of $606.38 million for the quarter.

Orion OYJ Company Profile

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.